ciprofloxacin has been researched along with cysteine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Salaspuro, V | 1 |
| Hidalgo, AA; Millanao, AR; Mora, AY; Mora, GC; Saavedra, CP; Valenzuela, LM; Villagra, NA | 1 |
| Chen, F; Tang, Y; Wang, C; Wang, J; Xu, Y; Zheng, H | 1 |
| Dong, H; Girmatsion, M; Guo, Y; Lu, G; Qian, H; Wang, R; Xie, Y; Yao, W | 1 |
| Cristino, S; Girolamini, L; Grottola, A; Mazzotta, M; Orsini, M; Pascale, MR; Salaris, S; Zini, N | 1 |
2 review(s) available for ciprofloxacin and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological treatments and strategies for reducing oral and intestinal acetaldehyde.
Topics: Acetaldehyde; Alcohol Drinking; Bacteria; Chlorhexidine; Ciprofloxacin; Cysteine; Gastrointestinal Neoplasms; Humans; Intestinal Mucosa; Intestines; Lactulose; Mouth; Mouthwashes; Smoking | 2007 |
4 other study(ies) available for ciprofloxacin and cysteine
| Article | Year |
|---|---|
Cysteine auxotrophy drives reduced susceptibility to quinolones and paraquat by inducing the expression of efflux-pump systems and detoxifying enzymes in S. Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cysteine; Drug Resistance, Multiple, Bacterial; Gene Deletion; Gene Expression; Genes, Bacterial; Humans; Levofloxacin; Membrane Transport Proteins; Mutation; Nalidixic Acid; Paraquat; Quinolones; Reactive Oxygen Species; Salmonella typhimurium; Sulfur | 2019 |
Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.
Topics: Acinetobacter baumannii; Acute-Phase Proteins; Amino Acid Sequence; Animals; Anti-Infective Agents; Arginine; Carrier Proteins; Ciprofloxacin; Cysteine; Defensins; Drug Resistance, Microbial; Humans; Lipopolysaccharides; Membrane Glycoproteins; Mice; Models, Molecular; Molecular Structure; NF-kappa B; Protein Binding; Protein Conformation; RAW 264.7 Cells; Signal Transduction; Structure-Activity Relationship; Toll-Like Receptor 4 | 2019 |
Construction of fluorescent logic gates for the detection of mercury(II) and ciprofloxacin based on phycocyanin.
Topics: Biosensing Techniques; Ciprofloxacin; Cysteine; Logic; Mercury; Phycocyanin | 2022 |
Topics: Agar; Bacterial Typing Techniques; Base Composition; Catalase; Charcoal; Ciprofloxacin; Cycloheximide; Cysteine; DNA, Bacterial; Fatty Acids; Gelatinases; Glycine; Hippurates; Legionella; Nucleotides; Phylogeny; Polymyxin B; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Water | 2022 |